Literature DB >> 10920055

What type of beta-blocker should be used to treat chronic heart failure?

M R Bristow.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10920055     DOI: 10.1161/01.cir.102.5.484

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  7 in total

1.  Contractile responses to selective phosphodiesterase inhibitors following chronic beta-adrenoreceptor activation.

Authors:  Oleg E Osadchii; Angela J Woodiwiss; Gavin R Norton
Journal:  Pflugers Arch       Date:  2005-12-17       Impact factor: 3.657

Review 2.  Metoprolol: a review of its use in chronic heart failure.

Authors:  A Prakash; A Markham
Journal:  Drugs       Date:  2000-09       Impact factor: 9.546

Review 3.  The management of diabetic neuropathy in CKD.

Authors:  Rodica Pop-Busui; Laurel Roberts; Subramaniam Pennathur; Mathias Kretzler; Frank C Brosius; Eva L Feldman
Journal:  Am J Kidney Dis       Date:  2009-12-30       Impact factor: 8.860

Review 4.  Carvedilol: a review of its use in chronic heart failure.

Authors:  Gillian M Keating; Blair Jarvis
Journal:  Drugs       Date:  2003       Impact factor: 9.546

5.  Inverse agonism and its therapeutic significance.

Authors:  Gurudas Khilnani; Ajeet Kumar Khilnani
Journal:  Indian J Pharmacol       Date:  2011-09       Impact factor: 1.200

Review 6.  Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives.

Authors:  M Merlo; T Caiffa; M Gobbo; L Adamo; G Sinagra
Journal:  Int J Cardiol Heart Vasc       Date:  2018-03-08

7.  Postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting or cardiac valve surgery: intraoperative use of landiolol.

Authors:  Kazuhiro Nakanishi; Shinhiro Takeda; Chol Kim; Shusuke Kohda; Atsuhiro Sakamoto
Journal:  J Cardiothorac Surg       Date:  2013-01-24       Impact factor: 1.637

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.